• MAHIMA SHARMA

COVID - 19 Pandemic was the major public threat worldwide that required immediate action. To develop a new successful drug or vaccine was time consuming process that’s why drug repurposing was the fastest mean to meet the urgency of situation. The present study was done to identify that which antibiotic was better to control the symptoms of SARS-CoV-2. For this purpose we employed a broad search strategy by systematic review of relevant eligible articles and publications. The data were also extracted from applied treatment results published in authentic media resources worldwide. Cefuroxime the 2nd generation cephalosporine was found to be an efficient and promising tool against COVID-19. One of the basic reasons for cefuroxime being a top ranked potential antibiotic is that it works as a multitarget inhibitor for 3-SARS-cov-2 proteins. It was 5th highest drug with binding energy -54.25 kcal/mal.

Cefuroxime, COVID-19, Proteins, Inhibitor, SARS-CoV-2, Repurposing,

"CEFUROXIME ANTIBIOTIC AS A POWERFUL WEAPON AGAINST COVID-19: A REVIEW OF RECENT RESEARCHES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 1, page no.d75-d80, January-2022, Available :http://www.jetir.org/papers/JETIR2201310.pdf

"CEFUROXIME ANTIBIOTIC AS A POWERFUL WEAPON AGAINST COVID-19: A REVIEW OF RECENT RESEARCHES", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 1, page no. ppd75-d80, January-2022, Available at : http://www.jetir.org/papers/JETIR2201310.pdf